{
  "id": 171151,
  "title": "Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge",
  "url": "https://urgent.news/2026/08/05/eli-lilly-easily-tops-quarterly-estimates-raises-outlook-as-zepbound-171151",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T10:57:06.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/08/05/eli-lilly-lly-earnings-q2-2026.html"
  },
  "original_language": "en",
  "account": "Eli Lilly reported a robust second-quarter earning and revenue that surpassed analysts' expectations, with its full-year sales outlook also increasing. The pharmaceutical company now anticipates 2026 revenue between $85 billion and $87 billion, a slight rise from its previous forecast of $82 billion to $85 billion. Eli Lilly's projected full-year adjusted profit per share is now between $35.50 and $36.50, compared to the earlier range of $35.50 to $37. The company raised its underlying profit guidance by $2.78 per share, however, this was offset by $3.03 per share in charges linked to deals made in the quarter. Shares of Lilly surged more than 5% in premarket trading on Wednesday, driven by robust demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro. The company expects significant M&A activity as it capitalizes on the financial windfall generated by its obesity and diabetes drugs.",
  "summary": "Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.",
  "key_points": [
    "Eli Lilly exceeds quarterly estimates with strong sales",
    "Company raises full-year revenue and profit outlook",
    "Zepbound and Mounjaro drive significant demand"
  ],
  "editors_take": null,
  "illustration": "https://urgent.news/ill/171151.png",
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC World",
        "title": "Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge",
        "url": "https://urgent.news/2026/08/05/eli-lilly-easily-tops-quarterly-estimates-raises-outlook-as-zepbound-172211",
        "published": "2026-08-05T10:57:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}